GXO: the cash flow

MyFinsight

For the quarter ending 2026-03-31, GXO had -$60M decrease in cash & cash equivalents over the period. -$34M in free cash flow.

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net income (loss)	5	43	60	-67
Depreciation and amortization expense	115	120	118	219
Goodwill and intangibles write-down loss held for sale	-	25	-	-
Stock-based compensation expense	10	13	11	23
Deferred tax benefit	-3	-5	1	-25
Other	-2	1	-4	-7
Accounts receivable	26	12	94	-18
Other assets	2	19	-1	-39
Accounts payable	-39	30	60	-151
Accrued expenses and other liabilities	-31	-24	71	-31
Net cash provided by operating activities	31	170	232	32
Capital expenditures	65	55	144	125
Proceeds from sale of property and equipment	3	48	99	2
Acquisition of business, net of cash acquired	-	0	0	0
Net investment hedges settlement	-	23	1	-
Other	-	-3	-	-
Net cash used in investing activities	-62	-27	-46	-123
Common stock repurchased	0	0	0	200
Net borrowings under revolving credit facilities	-	-	-	8
Proceeds from long-term debt, net of issuance discount	-	577	-	-
Proceeds from debt, net	-	-	0	0
Payments for debt issue costs	-	2	-	-
Net borrowings under revolving credit facilities	0	-63	38	-
Repayments of debt	-	124	1	55
Repayments of finance lease obligations	14	12	14	24
Proceeds from exercise of stock options	7	-	-	-
Taxes paid related to net share settlement of equity awards	15	1	1	7
Net changes in bank overdraft positions	-	-	-	64
Other	-4	2	11	-13
Net cash used in financing activities	-26	377	-39	-227
Effect of exchange rates on cash and cash equivalents	-3	-7	-10	40
Net decrease in cash, restricted cash and cash equivalents	-60	513	137	-278
Cash, restricted cash and cash equivalents, beginning of period	857	344	485	-
Cash, restricted cash and cash equivalents, end of period	797	857	344	-

Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.